StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$2.77M. The highest annual figure on record is -$190.01K in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.77M–
FY2024Dec 31, 2024-$1.07M–
FY2023Dec 31, 2023-$3.44M–
FY2022Dec 31, 2022-$13.88M–
FY2021Dec 31, 2021-$14.94M–
FY2020Dec 31, 2020-$729.39K–
FY2019Dec 31, 2019-$190.01K–
FY2018Dec 31, 2018-$2.73M–

More NewcelX figures

See a number that looks wrong?